◆ 会议时间：2019年10月10-13日
◆ 会议地点：德国 幕尼黑
◆ 会议简介：
2019年第15届国际异种移植协会大会(IXA 2019)将于2019年10月10-13日在德国幕尼黑举行，会议由国际异种移植协会(IXA)主办，每两年举行一届。大会计划将重点介绍当前异种移植研究的突破性进展及其在临床应用方面的发展。具体会议将从不同的角度讨论异种移植的监管和伦理问题。此外，还将讨论治疗慢性器官衰竭的补充方法，如干细胞疗法和机械辅助装置，以及它们在特定患者群体中的潜在应用。
国际异种移植协会(IXA)隶属于国际器官移植协会(TTS)，于1998年在蒙特利尔召开的移植学会大会上成立，旨在为那些对异种移植有特殊兴趣的人士提供一个交流的平台。国际器官移植协会(TTS)是成立于1966年，是一个致力于在世界范围内推进器官移植的国际非政府组织。TTS现在全球105个国家拥有超过6700名成员。TTS的使命是在人类移植实践中发挥全球领导力，制定临床实践指导方针，提供先进的教育计划，提高临床护理和科学研究的道德标准水平。TTS每两年组织一次世界大会，与会者超过5000人。
These are exciting times for Xenotransplantation. IXA is looking forward to its 15th Biennial Congress in Munich, Germany on October 10-13, 2019. Conveniently located in the heart of Europe, Munich is combining the dignified splendor of an old Bavarian kingdom with the vitality of a modern high-tech location. You will experience the exciting spirit of a modern capital with all kinds of social events and encounter the natural beauty of lakes and mountains nearby.
The congress program will highlight recent breakthroughs in xenotransplantation research and their development towards clinical application. Specific sessions will cover regulatory and ethical issues of xenotransplantation from different perspectives. In addition, complementary approaches for the treatment of chronic organ failures, such as stem cell-based therapies and mechanical assist devices, and their potential use for specific patient cohorts will be discussed.
摘要提交：
Submission deadline: May 1, 2019 May 12, 2019.
Notification of acceptance: June 17, 2019.
注册费：
Fees are in USD
| Registration Category |
Early Bird by July 15, 2019 |
Standard by September 9, 2019 |
Late/Onsite after September 10, 2019 |
| Member of IXA or TTS* |
$550.00 |
$625.00 |
$700.00 |
| Non-Member |
$850.00 |
$900.00 |
$950.00 |
| Student/Fellow/Trainee** |
$200.00 |
$225.00 |
$250.00 |
| Welcome Reception - Additional ticket*** |
$50.00 |
$50.00 |
$50.00 |
| Congress Dinner*** |
$100.00 |
$100.00 |
$100.00 |
| Congress Dinner - Student/Fellow/Trainee*** |
$35.00 |
$35.00 |
$35.00 |
◆ 参会对象：
政府代表、医院管理者、科室主任、副主任、医生及从相关领域研究的专家、科研人员、医药企业等。
|
